JPM
JPMorgan Chase & Co.
JPM's outlook is improving, though it still trails on the overall score.
MBBC
Marathon Bancorp, Inc.
MBBC has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MBBC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MBBC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MBBC.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
MBBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 23x | $14.90 | — |
| Cheap | 35x | $22.80 | +53% |
| Fair | 55x | $35.52 | +138% |
| Expensive | 155x | $101 | +575% |
Historical ranges are pointers, not guarantees.
MBBC has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
MBBC Forward outlook
There aren't enough analyst estimates for MBBC to show an outlook.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over MBBC on earnings, with more consistent year-over-year improvement.
MBBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.65 | +829% |
| Q2 2026 | $0.66 | +$0.69 |
| Q1 2026 | $0.37 | +118% |
| Q4 2025 | $0.24 | +$0.34 |
| Q3 2025 | $0.07 | +$0.10 |
| Q2 2025 | -$0.03 | +$0.04 |
| Q1 2025 | $0.17 | +143% |
| Q4 2024 | -$0.10 | -124% |
MBBC earned $0.65 per share over the past year, about nine times what it earned the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MBBC on profitability, with a higher operating margin.
MBBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.5M | +16% |
| Q2 2026 | $2.3M | +22% |
| Q1 2026 | $2.3M | +38% |
| Q4 2025 | $2.2M | +42% |
| Q3 2025 | $2.1M | +33% |
| Q2 2025 | $1.9M | +23% |
| Q1 2025 | $1.7M | +7.6% |
| Q4 2024 | $1.6M | -4.6% |
MBBC has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | -2.6 points |
| Q2 2026 | 17% | +40 points |
| Q1 2026 | 26% | +15 points |
| Q4 2025 | 26% | +23 points |
| Q3 2025 | 26% | +12 points |
| Q2 2025 | -23% | -27 points |
| Q1 2025 | 12% | +65 points |
| Q4 2024 | 3.3% | -11 points |
MBBC's operating margin was 23% last quarter, down 2.6 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MBBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6M | +242% |
| Q2 2026 | $54.1K | +$584.3K |
| Q1 2026 | $110.1K | -86% |
| Q4 2025 | $1.4M | +1233% |
| Q3 2025 | $456.6K | -50% |
| Q2 2025 | -$530.3K | -353% |
| Q1 2025 | $773.2K | +$1.8M |
| Q4 2024 | $105K | -62% |
MBBC has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over MBBC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MBBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +52.8K shares |
| 1 year | +3.4% | +91.6K shares |
| 3 years | -4% | -116K shares |
| 5 years | -5.4% | -158K shares |
MBBC has 3M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $148,875 |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over MBBC on leverage, with a lower net debt burden relative to earnings.
MBBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 7.0x | High |
| Q1 2026 | 13.8x | High |
| Q4 2025 | 14.3x | High |
| Q3 2025 | 19.7x | High |
| Q2 2025 | 41.7x | High |
| Q1 2025 | 16.6x | High |
| Q1 2024 | 34.2x | High |
MBBC's net debt is about 1.3 years of its operating earnings (EBITDA), down from 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MBBC.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MBBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 47.1 | Neutral |
MBBC's weekly RSI is 53 (neutral) and its Stochastic is 47 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over MBBC on valuation relative to its sector.
MBBC PE vs Financial Services Sector
| Metric | MBBC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 13x | 76% above |
| PE % | 11 | 19 | 8 pts below |
MBBC is trading at 23x earnings, a 76% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has stronger trend alignment. JPM is above 4 of 5 weekly averages versus MBBC above 2 of 3.
MBBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 0.3% above |
| 20 week MA | $15.0 | 0.7% below |
| 50 week MA | $14.1 | 5.4% above |
MBBC's trend is mixed: it's above two of its three weekly moving averages, and 5.4% above its 50-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
MBBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $7.49 | $12.2 | +63% |
| 2026 YTD | $12.2 | $14.9 | +22% |
MBBC has the edge over JPM on returns for 2026, with the stronger performance.